Reflect Scientific Secures $150,000 Blanket Order Contract from Long-Standing Biotech Client
Reflect Scientific (OTCQB: RSCF) has secured a $150,000 blanket order contract from a long-standing biotech client for consumable products. The contract spans five months, with revenue recognition split between Q4 2024 and Q1 2025. The partnership, which began in 2015, has supported the client through their development phase and commercialization of technology. The consumable products are part of Reflect Scientific's core offering to the biotechnology sector, where they provide cryogenic cooling solutions for biotechnology, pharmaceutical, medical, and transportation markets.
Reflect Scientific (OTCQB: RSCF) ha ottenuto un contratto di ordine generale di $150.000 da un cliente biotech di lunga data per prodotti di consumo. Il contratto ha una durata di cinque mesi, con il riconoscimento dei ricavi suddiviso tra il quarto trimestre del 2024 e il primo trimestre del 2025. La partnership, iniziata nel 2015, ha supportato il cliente durante la fase di sviluppo e commercializzazione della tecnologia. I prodotti di consumo fanno parte dell'offerta principale di Reflect Scientific per il settore biotecnologico, dove forniscono soluzioni di raffreddamento criogenico per i mercati biotecnologici, farmaceutici, medici e dei trasporti.
Reflect Scientific (OTCQB: RSCF) ha asegurado un contrato de pedido general de $150,000 de un cliente biotecnológico de larga data para productos de consumo. El contrato abarca cinco meses, con el reconocimiento de ingresos dividido entre el cuarto trimestre de 2024 y el primer trimestre de 2025. La asociación, que comenzó en 2015, ha respaldado al cliente durante su fase de desarrollo y comercialización de tecnología. Los productos de consumo son parte de la oferta principal de Reflect Scientific para el sector biotecnológico, donde proporcionan soluciones de refrigeración criogénica para los mercados biotecnológico, farmacéutico, médico y de transporte.
Reflect Scientific (OTCQB: RSCF)는 오랜 비 biotech 클라이언트로부터 150,000 달러의 블랭킷 계약을 체결하였습니다. 계약 기간은 5개월이며, 수익 인식은 2024년 4분기와 2025년 1분기로 나뉘어 집니다. 2015년부터 시작된 파트너십은 고객이 기술 개발 및 상용화 단계에서 지원을 제공해왔습니다. 이러한 소비재는 Reflect Scientific의 바이오테크 부문 핵심 제공의 일환으로, 바이오테크, 제약, 의료 및 운송 시장을 위한 크라이오제닉 냉각 솔루션을 제공합니다.
Reflect Scientific (OTCQB: RSCF) a obtenu un contrat d'ordre général de 150 000 $ d'un client biotech de longue date pour des produits consommables. Le contrat s'étend sur cinq mois, avec une reconnaissance des revenus partagée entre le quatrième trimestre 2024 et le premier trimestre 2025. Le partenariat, qui a débuté en 2015, a soutenu le client pendant sa phase de développement et de commercialisation de la technologie. Les produits consommables font partie de l'offre principale de Reflect Scientific pour le secteur biotechnologique, où ils fournissent des solutions de refroidissement cryogénique pour les marchés de la biotechnologie, de la pharmacie, de la médecine et du transport.
Reflect Scientific (OTCQB: RSCF) hat einen Rahmenvertrag über 150.000 US-Dollar von einem langjährigen Biotech-Kunden für Verbrauchsmaterialien gesichert. Der Vertrag erstreckt sich über fünf Monate, wobei die Umsatzrealisierung zwischen dem 4. Quartal 2024 und dem 1. Quartal 2025 aufgeteilt wird. Die Partnerschaft, die 2015 begann, hat den Kunden während der Entwicklungsphase und der Kommerzialisierung der Technologie unterstützt. Die Verbrauchsmaterialien sind Teil des Kernangebots von Reflect Scientific im Biotechnologiesektor, wo sie kryogene Kühlungslösungen für die Bereiche Biotechnologie, Pharma, Medizin und Transport bereitstellen.
- Secured new $150,000 contract for consumable products
- Revenue to be recognized across Q4 2024 and Q1 2025
- Demonstrates continued business relationship with existing client since 2015
- None.
OREM, Utah, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Reflect Scientific Inc. (OTCQB: RSCF), a leading provider of innovative products and technologies for the biotechnology, pharmaceutical, and transportation industries, today announced the receipt of a
The contract covers consumable products to be delivered over five months, with revenues to be recognized in the fourth quarter of 2024 and the first quarter of 2025. This latest agreement builds upon a successful partnership that began in 2015, during which Reflect Scientific has supported the client through their initial development phase and subsequent commercialization of groundbreaking technology.
"This contract represents the continuation of a valued long-term relationship and demonstrates our products' essential role in our clients' operations," said Mr. Kim Boyce, CEO of Reflect Scientific. "Our ability to maintain and grow these established partnerships speaks to the quality of our products and the strength of our customer service."
The consumable products covered under this contract are part of Reflect Scientific's core product offering to the biotechnology sector, where the Company has established itself as a trusted supplier of critical materials and equipment.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol "RSCF" and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading "Disclosure," including those identified in such filings as "forward-looking statements."
FAQ
What is the value of Reflect Scientific's (RSCF) latest contract announced in November 2024?
When will Reflect Scientific (RSCF) recognize revenue from the new $150,000 contract?
What type of products does Reflect Scientific (RSCF) supply under the new contract?
